https://www.wsj.com/health/pharma/eli-lilly-preparing-retatrutide-applications-after-positive-weight-loss-data-86865393
It’s far superior
It’s far superior
The Wall Street Journal
Eli Lilly Preparing Retatrutide Applications After Positive Weight-Loss Data
Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide, following data from two Phase 3 trials showing the treatment delivered substantial results.